Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Eye cancer, intraocular melanoma
Near ZIP Code:  within 100 miles of 20892
Results 1-3 of 3 for your search:
Start Over
Combination Chemotherapy and Tumor Infiltrating Lymphocytes with or without High Dose Aldesleukin in Treating Patients with Metastatic Ocular Melanoma
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 13-C-0093, NCI-2013-01586, 130093, P131209, NCT01814046
Cabozantinib-S-Malate Compared with Temozolomide or Dacarbazine in Treating Patients with Melanoma of the Eye
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A091201, NCI-2013-00821, CALGB-A091201, NCT01835145
INCB024360 and Vaccine Therapy in Treating Patients with Stage III-IV Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-04, NCI-2013-01605, NCT01961115
Start Over